Novartis AG
BIOMARKERS FOR EVALUATING CAR-T CELLS TO PREDICT CLINICAL OUTCOME
Last updated:
Abstract:
The invention provides biomarkers, e.g, cancer biomarkers, and methods of using said biomarkers. Specifically, the invention provides biomarkers for use, e.g., in evaluating CAR-T cell therapies and predicting clinical outcome.
Status:
Application
Type:
Utility
Filling date:
1 May 2019
Issue date:
23 Dec 2021